Intrexon Corporation (XON) Trading 7.8% Higher

Intrexon Corporation (NYSE:XON)’s share price traded up 7.8% during mid-day trading on Thursday . The stock traded as high as $14.09 and last traded at $13.34. 2,727,349 shares changed hands during trading, an increase of 139% from the average session volume of 1,141,586 shares. The stock had previously closed at $12.37.

Several equities analysts have recently issued reports on the stock. Northland Securities reaffirmed a “buy” rating and set a $21.00 price target on shares of Intrexon Corporation in a research note on Friday, November 10th. Bank of America Corporation dropped their price target on shares of Intrexon Corporation from $25.00 to $21.00 and set a “neutral” rating for the company in a research note on Friday, November 10th. Stifel Nicolaus raised their price target on shares of Intrexon Corporation from $39.00 to $57.00 and gave the company a “buy” rating in a research note on Friday, November 10th. Zacks Investment Research downgraded shares of Intrexon Corporation from a “hold” rating to a “sell” rating in a research note on Monday, October 16th. Finally, Griffin Securities reiterated a “buy” rating and set a $55.00 price objective on shares of Intrexon Corporation in a research report on Friday, October 6th. Two investment analysts have rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $38.50.

The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.85 and a current ratio of 2.05.

Institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. increased its position in shares of Intrexon Corporation by 3.4% during the second quarter. Vanguard Group Inc. now owns 4,433,879 shares of the biotechnology company’s stock worth $106,811,000 after buying an additional 147,517 shares during the period. Goldman Sachs Group Inc. increased its position in shares of Intrexon Corporation by 60.0% during the first quarter. Goldman Sachs Group Inc. now owns 144,428 shares of the biotechnology company’s stock worth $2,862,000 after buying an additional 54,179 shares during the period. Virtu KCG Holdings LLC acquired a new stake in shares of Intrexon Corporation during the second quarter worth $593,000. Trellus Management Company LLC acquired a new stake in shares of Intrexon Corporation during the third quarter worth $475,000. Finally, Bank of New York Mellon Corp increased its position in shares of Intrexon Corporation by 7.1% during the second quarter. Bank of New York Mellon Corp now owns 234,139 shares of the biotechnology company’s stock worth $5,640,000 after buying an additional 15,568 shares during the period. Institutional investors own 77.17% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Intrexon Corporation (XON) Trading 7.8% Higher” was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another website, it was stolen and reposted in violation of United States & international copyright & trademark legislation. The correct version of this story can be read at https://www.com-unik.info/2017/11/25/intrexon-corporation-xon-trading-7-8-higher.html.

Intrexon Corporation Company Profile

Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company’s domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components.

What are top analysts saying about Intrexon Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Intrexon Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit